All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Nubeqa 300mg Tablet
Prescription Required
Salt Composition : Darolutamide
Manufacturer : BAYER PHARMACEUTICALS PVT LTD
Origin of Medicine : Germany
112 Tablet(s) In A Bottle
PAP Information : Â Â Contact us for latest updates.
Program Overview: BAYER PHARMACEUTICALS PVT LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Nubeqa 300mg Tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Nubeqa Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Darolutamide 300mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Bayer can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: BAYER PHARMACEUTICALS PVT LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Nubeqa 300mg Tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Nubeqa Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Darolutamide 300mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Bayer can avail of it without having to purchase the medication from MrMed.
Introduction to Nubeqa 300mg Tablet
Nubeqa 300mg tablet consists of the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Prostate cancer occurs when the prostate cells start multiplying and dividing abnormally. Do not take this medicine if you are allergic to darolutamide or any other ingredient in it.  Â
Effective contraception is to be taken while using Nubeqa 300mg Tablet, and it must be continued till one week after the last dose with this medication to prevent pregnancy. Before starting treatment with this medication, inform your doctor if you have any liver problems, kidney problems, heart conditions, or allergic conditions. Â
Nubeqa 300mg tablet may cause infertility in men, hence discuss your fertility concerns with your doctor before beginning treatment with this medication. Inform your doctor if you are lactose intolerant before starting treatment with this medication, as it contains lactose. Fatigue, rash, and pain in muscle, bone, arms, and legs are common side effects of this medication.Â
Uses of Nubeqa 300mg Tablet
- Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment)
- Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.
Therapeutic Effects of Nubeqa 300mg Tablet
Nubeqa 300mg tablet works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells.Â
Interaction of Nubeqa 300mg Tablet with other drugs
Inform your doctor about any prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medicines may interact with Nubeqa 300mg tablet and can cause undesirable side effects.Â
More Information about Nubeqa 300mg Tablet
- Keep Darolutamide out of sight and reach of children.
- This medication is to be stored at or below 30 °C.
- If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose. Inform your physician about the missed dose. Do not take 2 doses at the same time.
How to consume Nubeqa 300mg Tablet
Nubeqa 300mg tablet is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity.Â
Safety Advices for Nubeqa 300mg Tablet
 Â
Pregnancy
 Â
Nubeqa 300mg Tablet is only for use in men. This drug is not recommended for use in women, especially if they are pregnant, because it may cause harm to the unborn baby and result in loss of pregnancy. It is better to discuss with a doctor to use of an effective contraceptive method during the treatment and for 1 week after the last dose if your male partner is consuming this medicine. It is recommended to consult your physician if you are pregnant already or suspect pregnancy. Â
 Â
Breast Feeding
 ÂNubeqa 300mg tablet is not indicated in females. It is unknown whether this medicine is excreted in human milk. It is difficult to rule out benefits over risk for the nursing infant, hence it should not be used during breastfeeding.Â
 Â
Lungs
 Â
It is unknown whether Nubeqa 300mg Tablet can be administered to patients with lung diseases. Inform your doctor if you have any lung problems before starting the treatment.Â
 Â
Liver
  Nubeqa 300mg tablet is safe to use in patients having mild liver conditions if prescribed by your healthcare provider. Inform your doctor about any liver conditions you have before starting treatment with this medication.Â
 Â
Alcohol
 ÂIt is unknown whether it is safe to consume alcohol with Nubeqa 300mg tablet. It is advised to consult your physician for more advice.
 Â
Driving
  It is safe to drive while using Nubeqa 300mg Tablet, as it is unlikely to affect the ability to drive.Â
Side Effects of Nubeqa 300mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Â
Common:
- Fatigue
- Rash
- Muscle pain
- Bone pain
- Pain in the arms and legs
- Broken bonesÂ
Serious:
- Chest pain
- Pain in arms, jaw, neck and back
- Lightheadedness or dizzy
- Shortness of breath
- Swelling of ankles and legs
- Seizures
Word of Advice
Inform your physician if you are facing any symptoms of seizures, swelling in legs, ankle, and face, abdominal pain, shortness of breath, and chest pain after taking this medicine. Notify your physician if you are taking any antibiotics, cholesterol medications, and other prescribed medicines. Nubeqa 300mg tablet is not indicated in children and adolescents less than 18 years of age. Pregnant and breastfeeding women should not consume this medication since this is used to treat prostate cancer.Â
FAQs
Q 1. What happens when women consume Nubeqa 300mg tablet unknowingly?
Nubeqa 300mg tablet is not indicated for women. If the medicine has been taken unknowingly, inform your doctor immediately and seek medical advice.
Q 2. What is the Nubeqa 300mg tablet package insert?
The FDA provides a package insert, which summarizes the relevant scientific information needed for healthcare practitioners and patients to use the drug safely and effectively. The Nubeqa 300mg tablet package insert contains safety information, instruction for use, and other information.
Q 3. Can Nubeqa 300mg tablet be crushed?
Do not break, crush or chew the tablet. Nubeqa 300mg tablet should be taken as a whole, and swallow with water.
Q 4. Will Nubeqa 300mg tablet lowers prostate-specific antigen?
Yes, Nubeqa 300mg tablet lowers PSA levels, and it prevents cancer from spreading to other parts of the body.
Q 5. What is the use of Nubeqa 300mg tablet?
It is used to treat patients having hormone-sensitive non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment) in combination with other anti-cancer medication.
Fact Box of Nubeqa 300mg Tablet
Molecule name: Darolutamide | Therapeutic class: Anti-cancer |
Pharmacological class:Â Androgen receptor inhibitor | Indications: Treatment for prostate cancer |
References
- Bayer (Pty) Ltd, Patient information leaflet, [Revised on 15th March 2022], [Accessed on 8th August 2022], https://www.bayer.com/sites/default/files/NUBEQA_EN_PIL.pdf#page=2Â
- Orion Corporation, Orion Pharma, Electronics Medicine Compendium (emc), [Revised on January 2021], [Accessed on 8th August 2022], https://www.medicines.org.uk/emc/files/pil.11324.pdfÂ
- Â Bayer HealthCare Pharmaceuticals Inc, U.S. Food and Drug Administration, [Revised on July 2019], [Accessed on 8th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdfÂ
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: hormones and related agents, 12th edition, 2011, 1707 - 1709.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
